Skip to main content
. 2016 Feb 25;2016:5035127. doi: 10.1155/2016/5035127

Table 2.

Correlation between pT category and pathological features with localized 237 RCC cases.

pT1a versus pT1b pT1a and pT1b versus pT2a pT1a, pT1b, and pT2a versus pT2b
Odds ratio (95% CI) p value Odds ratio (95% CI) p value Odds ratio (95% CI) p value
94 versus 74 168 versus 43 211 versus 26
Cases of each category Cases of each category Cases of each category
Cell type 2.43 (0.85–6.89) 0.09 2.28 (0.76–6.82) 0.13 2.32 (0.84–6.36) 0.10
Clear versus others 139 versus 29 175 versus 36 190 versus 47
Nuclear grade 1.79 (0.57–5.56) 0.31 5.15 (1.87–14.2) 0.0015 3.39 (1.20–9.58) 0.020
Low versus high 147 versus 21 176 versus 35 190 versus 47
MVI 1.95 (0.92–4.16) 0.08 3.08 (1.47–6.48) 0.002 2.91 (1.19–7.11) 0.018
(−) versus (+) 123 versus 45 144 versus 67 154 versus 83
MMP-2 1.14 (0.55–2.36) 0.71 2.13 (0.90–5.0) 0.84 1.24 (0.41–3.70) 0.70
Weak versus strong 60 versus 108 76 versus 135 82 versus 156
MMP-9 1.79 (0.65–4.90) 0.205 1.47 (0.55–3.94) 0.43 1.31 (0.40–4.21) 0.64
Weak versus strong 134 versus 34 163 versus 48 181 versus 56
TIMP-1 3.30 (1.32–8.26) 0.010 1.18 (0.43–3.26) 0.74 1.59 (0.49–5.10) 0.42
Weak versus strong 31 versus 137 37 versus 174 42 versus 195
TIMP-2 1.41 (0.48–4.13) 0.53 2.14 (0.65–6.99) 0.84 3.03 (0.71–12.98) 0.13
Weak versus strong 142 versus 26 178 versus 33 201 versus 36
MT-MMP-1 1.93 (0.65–5.71) 0.096 2.28 (0.76–3.50) 0.15 1.98 (0.60–6.54) 0.26
Weak versus strong 144 versus 26 176 versus 35 194 versus 43

MVI: microvascular invasion.